Breaking News Instant updates and real-time market news.

PEN

Penumbra

$84.10

0.9 (1.08%)

08:11
08/09/17
08/09
08:11
08/09/17
08:11

Penumbra price target raised to $100 from $94 at Canaccord

Canaccord analyst Jason Mills raised his price target on Penumbra to $100 from $94 following Q2 results. The analyst noted an acceleration in its stroke business and expects the company to deliver robust growth for multiple years. Mills reiterated his Buy rating on Penumbra shares.

PEN Penumbra
$84.10

0.9 (1.08%)

05/10/17
ADAM
05/10/17
NO CHANGE
Target $94
ADAM
Buy
Penumbra should be bought on any pullback, says Canaccord
Canaccord analyst Jason Mills said Penumbra should be bought on any pullback and it should be bought and held as opposed to traded. He said the company has multiple growth levers to pull and he sees robust growth from many years to come in many of its businesses. Mills reiterated his Buy rating and raised his price target to $94 from $91 on Penumbra shares.
05/10/17
BMOC
05/10/17
NO CHANGE
BMOC
Penumbra price target raised to $96 from $86 at BMO Capital
BMO Capital analyst Joanne K. Wuensch raised her price target on Penumbra after the company reported higher than expected revenue. She thinks that "the shift toward mechanical thrombectomy for stroke treatment remains a significant driver" for the stock, and she keeps an Outperform rating on the shares.
06/14/17
ADAM
06/14/17
NO CHANGE
Target $94
ADAM
Buy
Penumbra 3D recall likely an immaterial event, says Canaccord
Canaccord analyst Jason Mills noted Penumbra issued a voluntary field recall of four lots of its 3D stent retriever following a few issues of SR breaking and/or unraveling. The lots were built in the U.S. so this should not impact Canada or European sales and 3D sales are not material to the analyst's model in 2017. As a result, he believes the recall is immaterial and so reiterated Penumbra as a top pick. Mills also reiterated his Buy rating and $94 price target on Penumbra shares.
07/17/17
ADAM
07/17/17
NO CHANGE
ADAM
M&A in med-tech space will accelerate, says Canaccord
Canaccord analyst Jason Mills remains cautious in the med-tech space but believes M&A will continue to be a major theme. He noted the sector is trading at peak levels and recommends trading around core positions and looking for pullbacks to average down in favorite names. He said the most likely takeout names, in this order, are, Nevro (NVRO), AtriCure (ATRC), NxStage Medical (NXTM), iRhythm (IRTC), and Penumbra (PEN).

TODAY'S FREE FLY STORIES

13:35
11/22/17
11/22
13:35
11/22/17
13:35
General news
Treasury Action: yields have drifted lower »

Treasury Action: yields…

CERN

Cerner

$66.68

0.95 (1.45%)

, AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

13:33
11/22/17
11/22
13:33
11/22/17
13:33
Recommendations
Cerner, Amazon.com analyst commentary  »

Amazon pact, as…

CERN

Cerner

$66.68

0.95 (1.45%)

AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 18

    Mar

13:30
11/22/17
11/22
13:30
11/22/17
13:30
General news
Oil Action: Baker Hughes »

Oil Action: Baker Hughes…

CHRW

C.H. Robinson

$78.79

0.36 (0.46%)

13:25
11/22/17
11/22
13:25
11/22/17
13:25
Options
CH Robinson Worldwide call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 09

    Jan

$NSD

NASDAQ Market Internals

13:17
11/22/17
11/22
13:17
11/22/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
11/22/17
11/22
13:16
11/22/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:05
11/22/17
11/22
13:05
11/22/17
13:05
General news
Canada retail sales preview »

Canada retail sales…

BHGE

Baker Hughes

$30.68

0.02 (0.07%)

13:03
11/22/17
11/22
13:03
11/22/17
13:03
Hot Stocks
Baker Hughes reports U.S. rig count up 8 to 923 rigs »

Baker Hughes reported the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

HON

Honeywell

$149.34

-0.014 (-0.01%)

13:00
11/22/17
11/22
13:00
11/22/17
13:00
Options
Defensive option play in Honeywell as shares ease off 52-week highs »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCLR

Oclaro

$6.86

0.37 (5.70%)

12:50
11/22/17
11/22
12:50
11/22/17
12:50
Options
Opening activity in Oclaro calls that expire next week »

Opening activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 12

    Dec

DE

Deere

$145.30

6.07 (4.36%)

, HPQ

HP Inc.

$21.02

-1.445 (-6.43%)

12:36
11/22/17
11/22
12:36
11/22/17
12:36
General news
On The Fly: Top stock stories at midday »

Stocks began the session…

DE

Deere

$145.30

6.07 (4.36%)

HPQ

HP Inc.

$21.02

-1.445 (-6.43%)

HPE

HP Enterprise

$13.02

-1.1 (-7.79%)

GME

GameStop

$17.86

1.13 (6.75%)

GES

Guess

$15.80

-2.15 (-11.98%)

GKOS

Glaukos

$23.96

-1.39 (-5.48%)

ROK

Rockwell Automation

$190.25

-2.77 (-1.44%)

EMR

Emerson

$61.78

1.425 (2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 27

    Nov

  • 28

    Nov

  • 11

    Dec

12:35
11/22/17
11/22
12:35
11/22/17
12:35
General news
U.S. VIX equity volatility probed 1-month lows of 9.32 »

U.S. VIX equity…

IRBT

iRobot

$73.07

0.95 (1.32%)

12:26
11/22/17
11/22
12:26
11/22/17
12:26
Hot Stocks
iRobot weakness attributed to steeper Roomba discounts »

Shares of iRobot (IRBT)…Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$35.09

0.28 (0.80%)

12:25
11/22/17
11/22
12:25
11/22/17
12:25
Options
GlaxoSmithKline call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBVX

MabVax Therapeutics

$0.71

0.0541 (8.26%)

12:25
11/22/17
11/22
12:25
11/22/17
12:25
Conference/Events
MabVax Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

$NSD

NASDAQ Market Internals

12:17
11/22/17
11/22
12:17
11/22/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
11/22/17
11/22
12:16
11/22/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHN

Achillion

$3.43

-0.02 (-0.58%)

, JNJ

Johnson & Johnson

$137.11

-1.23 (-0.89%)

12:10
11/22/17
11/22
12:10
11/22/17
12:10
Hot Stocks
Johnson & Johnson reports sale of 18.37M shares of Achillion »

In a regulatory filing,…

ACHN

Achillion

$3.43

-0.02 (-0.58%)

JNJ

Johnson & Johnson

$137.11

-1.23 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

XON

Intrexon

$13.69

1.315 (10.63%)

12:05
11/22/17
11/22
12:05
11/22/17
12:05
Options
Intrexon call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

, EBAY

eBay

$35.96

0.43 (1.21%)

12:04
11/22/17
11/22
12:04
11/22/17
12:04
Periodicals
Shoppers to spend 7.3% more online during Thanksgiving weekend, report says »

Shoppers are expected to…

AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

EBAY

eBay

$35.96

0.43 (1.21%)

WMT

Wal-Mart

$96.34

-0.18 (-0.19%)

KSS

Kohl's

$44.83

0.62 (1.40%)

TGT

Target

$57.64

0.3868 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 20

    Feb

  • 18

    Mar

PN

Patriot National

12:04
11/22/17
11/22
12:04
11/22/17
12:04
Hot Stocks
Patriot National slides after reporting forbearance agreement with lenders »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:00
11/22/17
11/22
12:00
11/22/17
12:00
General news
EIA natural gas storage change for week ending November 17 »

Gas inventories 46 Bcf…

12:00
11/22/17
11/22
12:00
11/22/17
12:00
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

PN

Patriot National

11:59
11/22/17
11/22
11:59
11/22/17
11:59
Hot Stocks
Breaking Hot Stocks news story on Patriot National »

Patriot National trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$56.41

-0.33 (-0.58%)

, DISH

Dish

$50.04

0.03 (0.06%)

11:59
11/22/17
11/22
11:59
11/22/17
11:59
Hot Stocks
CBS says still 'far apart' on terms with Dish for new deal »

CBS (CBS) issued the…

CBS

CBS

$56.41

-0.33 (-0.58%)

DISH

Dish

$50.04

0.03 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.